Purchase Order 19GE5023P0101
Award Date 7/11/23
Potential Completion Date 9/30/23
Potential Value $41K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Thailand
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Economy Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal purchase order award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the delivery of ONT MinION sequencing kits. The $21,577 firm-fixed-price contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, with a period of performance ending on September 29, 2024. No set-aside was used for this award. Oxford Nanopore Technologies is a prime contractor for this purchase order and...
- This is a $48,400.00 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the delivery of laboratory supplies, with no set-aside designation. Oxford Nanopore Technologies Inc. has secured numerous prime federal contracts and subcontracts with agencies like the NIH, USDA, and DOD, primarily for the provision of next-generation genomic sequencing...
- This firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit organization, to provide MINION-2 SEQUENCERS. The contract has a ceiling value of $38,062 and a completion date of October 9, 2020. Oxford Nanopore Technologies Inc. is a biotechnology company that develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins. The company has...
- This is a $95,755 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for the acquisition of GridION MK1 CAPEX equipment. The award has no set-aside designation. Oxford Nanopore Technologies Inc. has received multiple prime federal contract awards from agencies such as the NIH, USDA, and DOD to provide next-generation genomic sequencing platforms, consumables,...
- This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, is for the provision of sequencing technology and associated services to support research initiatives. The $20,210 firm fixed price purchase order, awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh, does not have a set-aside designation. Oxford Nanopore Technologies holds additional federal contract vehicles, including a $300,000 blanket purchase...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract, valued at $43,168.00, is for the delivery of a TEC-REAGENT KIT and has a completion date of September 15, 2022. Oxford Nanopore Technologies Inc. is a leading provider of nanopore-based sequencing equipment, consumables, and associated services to federal...
- This firm fixed-price purchase order, valued at $16,199.00, was awarded by the Centers for Disease Control and Prevention (CDC) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract provides for the delivery of Oxford Nanopore's VOLTRAX V2 CAPEX equipment, which is part of their nanopore-based electronic systems used for real-time analysis of genetic materials and other biological molecules. The contract has no set-aside designation. Oxford Nanopore...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $140,950 firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for the GRIDION MK1 CAPEX. The contract, which does not have a set-aside designation, is for the delivery of Oxford Nanopore's nanopore sequencing devices, flow cells, reagents, kits, software, and related services and support. The contract will be performed in Lexington,...
- The Department of Health and Human Services Centers for Disease Control and Prevention has awarded a firm fixed price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit company, to provide a GridION Mk1 capex sequencing system and associated lab equipment and supplies. The $126,680 contract has a completion date of December 13, 2022 and does not utilize a set-aside designation. Based on previous federal contract awards, Oxford Nanopore Technologies Inc. provides...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order contract to Oxford Nanopore Technologies Inc. to provide genomic sequencing equipment, consumables, and services. The $16,300.00 contract, which has no set-aside designation, was awarded on July 9, 2019 with a completion date of May 15, 2023. Oxford Nanopore Technologies Inc. is a foreign-owned, for-profit organization that develops nanopore-based electronic...